Dr. Aric Lee Gregson, MD

Dr. Gregson practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Gregson's NPI, 1588683007, was assigned on July 18, 2006. Dr. Gregson graduated from David Geffen School of Medicine at UCLA in 1997. Dr. Gregson holds California license A68156.

Dr. Gregson's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Gregson's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Gregson is also affiliated with Providence Saint John's Health Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Gregson to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gregson practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Gregson's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Gregson is board certified in infectious disease by the National Board of Physicians and Surgeons. Dmand AI has Dr. Gregson's licenses on file in 2 states: California and Maryland.

CMS data shows 2,051 Medicare services from Dr. Gregson across 4 procedure codes in 2024, for 591 Medicare patients. Medicare paid $201,538 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 591 Medicare patients who saw Dr. Gregson in 2024. The largest group is 75 to 84, with 183 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 3.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gregson's median patient age at 60, with 41% women.

In 2024, Dr. Gregson wrote 67 Medicare Part D claims for 17 patients. 78% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $54,467 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.

Dr. Gregson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Gregson, published from 2008 to 2018. 2015 was the busiest year, with 3. The most frequent topics are Administration, Intravenous, Ambulatory Care and Anti-Bacterial Agents. Dr. Gregson's most frequent co-authors are Ariss Derhovanessian, MD, Abbas Ardehali, MD and John A. Belperio, MD.

Dmand AI links Dr. Gregson to 1 clinical trial. Conditions studied include Primary Graft Dysfunction and Reperfusion Injury.

CMS Open Payments shows 9 general payments to Dr. Gregson from 4 drug and device companies from 2016 to 2020. Travel and lodging make up the largest share, 78% of the total. Jazz Pharmaceuticals Inc. paid the most, $843.

Dr. Gregson graduated from David Geffen School of Medicine at UCLA in 1997.

Dr. Gregson is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.